0001209191-17-018752.txt : 20170307 0001209191-17-018752.hdr.sgml : 20170307 20170307163710 ACCESSION NUMBER: 0001209191-17-018752 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170303 FILED AS OF DATE: 20170307 DATE AS OF CHANGE: 20170307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAPLAN GILLA CENTRAL INDEX KEY: 0001247024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 17672443 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 FORMER NAME: FORMER CONFORMED NAME: KAPLAN GILLA PHD DATE OF NAME CHANGE: 20030625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-03 0 0000816284 CELGENE CORP /DE/ CELG 0001247024 KAPLAN GILLA C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 1 0 0 0 Common Stock 2017-03-03 4 M 0 7500 25.575 A 87142 D Stock Options (Right to Buy) 25.575 2017-03-03 4 M 0 7500 D 2017-03-15 Common Stock 7500 0 D The option was fully exercisable. The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan. /s/ Peter N. Kellogg ___________________________________________________ Peter N. Kellogg, Attorney-in-Fact 2017-03-07